TYPE II DIABETES MELLITUS

This study is testing an investigational weekly injection called GL0034 for adults with type 2 diabetes who are also overweight or obese. The main goal is to see if the treatment can lower long-term blood sugar levels (HbA1c) and help with weight loss over 36 weeks. Participants …

This study aims to monitor the real-world safety and effectiveness of the diabetes medication empagliflozin, taken with or without metformin, in Pakistani adults. It will follow 2000 participants for up to 6 months to track side effects and how well the drug controls blood sugar …

This study aims to see if simple strategies can encourage people with prediabetes or type 2 diabetes to buy more whole grains instead of refined grains when shopping for groceries online. Researchers will test two approaches: using marketing nudges (like highlighting whole grain …

This study is testing a community-based program to prevent and control type 2 diabetes in rural Pakistan. Over 12,700 adults will participate in group meetings where they identify local health problems and plan solutions together. The goal is to see if this community-led approach…

This study is testing whether a community group program, where villagers meet to learn and plan actions together, can help prevent and control type 2 diabetes in rural Afghanistan. The research team will work with about 250 adults to see if this approach is practical and acceptab…

This early-stage study aims to understand how kidney function affects the body's processing of a new long-acting diabetes drug called GL0034. Researchers will give a single dose to about 40 adults with varying levels of kidney health, from normal to severe impairment. The goal is…